Taiyen Biotech Co., Ltd.

TWSE:1737 Stock Report

Market Cap: NT$6.5b

Taiyen Biotech Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Shi-Hui Chen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.9yrs
CEO ownershipn/a
Management average tenure2.1yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20

Jul 31
Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20

Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality

May 09
Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality

Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Apr 24
Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

Apr 09
Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Mar 25
A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Mar 12
Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

Feb 14
Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

Feb 01
Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Jan 17
Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

Jan 04
Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Dec 22
A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Dec 09
How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

Nov 24
Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

CEO

Shi-Hui Chen

3.9yrs

Tenure

Mr. Shi-Hui Chen serves as President at Taiyen Biotech Co., Ltd. since 2021. He served as Vice President of Taiyen Biotech Co., Ltd.He served as Spokesperson of Taiyen Biotech Co., Ltd. He served as Direc...


Leadership Team

NamePositionTenureCompensationOwnership
Shi-Hui Chen
President3.9yrsno datano data
Wei Su
Director of Financial Accounting Departmentno datano datano data
An-Ping Ho
Director of Administrative Department & Representative Directorless than a yearno datano data
Tung-Hsuan Yang
Director of Legal Affairs Officeno datano datano data
Chieh-Han Lee
VP & Director of Corporate Development Departmentno datano data0.00089%
NT$ 57.4k
Mei-Wen Chen
Director of Branding & Marketing Departmentno datano datano data
Mei-Yu Chuang
Chief Internal Auditor2.1yrsno datano data

2.1yrs

Average Tenure

Experienced Management: 1737's management team is considered experienced (2.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
An-Ping Ho
Director of Administrative Department & Representative Directorless than a yearno datano data
Yen-Che Ting
Chairman of the Boardless than a yearno datano data
Hsien-Kuei Liao
Directorno datano datano data
Kuan-Ping Chen
Director5.5yrsno datano data
Chien-Lung Chan
Independent Director5.5yrsno datano data
Shun-Tien Huang
Independent Director5.5yrsno datano data
Ying-Man Kuo
Independent Director5.5yrsno datano data
Shih-Hao Wu
Independent Director2.4yrsno datano data
Chia-Ling Lee
Independent Director2.4yrsno datano data
Yu-Pen Lin
Independent Director1.5yrsno datano data
Wei-I Chu
Representative Director1.4yrsno datano data

2.4yrs

Average Tenure

Experienced Board: 1737's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 21:59
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Taiyen Biotech Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullE.Sun Securities Investment Consulting Co. Ltd.
Titan HorngIBTS Investment Consulting Co., Ltd.
Zhennan LeeJih Sun Securities Investment Consulting Co., Ltd.